Crispr Therapeutics shares owned by Caitong International Asset Management
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Caitong International Asset Management
from 13F filings
Historical chart of Caitong International Asset Management investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Caitong International Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by Caitong International Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-06-30 | $90k | 1.8k | 48.64 |
More positions owned by Caitong International Asset Management
View all positions for Caitong International Asset Management